Ikarian Capital, LLC - ALTAMIRA THERAPEUTICS LTD ownership

ALTAMIRA THERAPEUTICS LTD's ticker is and the CUSIP is G0360L100. A total of 20 filers reported holding ALTAMIRA THERAPEUTICS LTD in Q1 2022. The put-call ratio across all filers is 0.26 and the average weighting 0.0%.

Quarter-by-quarter ownership
Ikarian Capital, LLC ownership history of ALTAMIRA THERAPEUTICS LTD
ValueSharesWeighting
Q2 2022$36,000
-89.7%
75,000
-76.6%
0.01%
-84.8%
Q1 2022$351,000
-36.5%
320,010
+5.0%
0.05%
-43.9%
Q4 2021$553,000
-31.1%
304,791
-23.6%
0.08%
+43.9%
Q3 2021$803,000399,1480.06%
Other shareholders
ALTAMIRA THERAPEUTICS LTD shareholders Q1 2022
NameSharesValueWeighting ↓
Ikarian Capital, LLC 320,010$351,0000.05%
BOOTHBAY FUND MANAGEMENT, LLC 30,753$34,0000.00%
Cutler Group LLC / CA 2,100$2,0000.00%
BARCLAYS PLC 1$00.00%
Gradient Investments LLC 1,000$1,0000.00%
Stonebridge Capital Advisors LLC 100$00.00%
UBS Group AG 3,486$4,0000.00%
OSAIC HOLDINGS, INC. 10$00.00%
WELLS FARGO & COMPANY/MN 500$1,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of ALTAMIRA THERAPEUTICS LTD shareholders